Global Health Technologies Coalition Global Health Technologies Coalition
  • Why R&D
  • R&D Facts
  • In Your State
  • Solutions
  • Breakthroughs Blog
  • News & Events
  • Resources
  • About Us
Stay Informed

Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

From the Breakthroughs Blog: CDC

Six issues to watch in US global health R&D policy in 2021
IAEA imagebank, NLO Office, Syrian Arab Republic
January 5, 2021

Six issues to watch in US global health R&D policy in 2021

2021 is shaping up to be an extraordinarily consequential year for US policy for global health and medical research, as a new presidential administration and Congress take charge against the backdrop of a global pandemic that has killed 1.6 million people worldwide and set back decades of progress in global health. As 2021 begins, here are some of the top policy issues GHTC will be tracking.
Marissa Chmiola GHTC
Read more
GHTC’s response to COVID-19
NIAID
July 28, 2020

GHTC’s response to COVID-19

The COVID-19 pandemic is a global health crisis affecting populations around the world. GHTC is tracking and responding to the pandemic through US and multilateral efforts.

Julien Rashid GHTC
Read more
Research Roundup: Ebola outbreak wanes, remdesivir prevents MERS coronavirus disease in monkeys, and Trump's budget would cut global health programs
PATH/Patrick McKern
February 17, 2020

Research Roundup: Ebola outbreak wanes, remdesivir prevents MERS coronavirus disease in monkeys, and Trump's budget would cut global health programs

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Ansley Kahn
GHTC
Read More
Research Roundup: Vaccine candidate for gestational malaria, FDA fast-tracks coronavirus diagnostic, and Zika vaccine induces potent Zika and dengue antibodies
PATH/Matthew Dakin
February 10, 2020

Research Roundup: Vaccine candidate for gestational malaria, FDA fast-tracks coronavirus diagnostic, and Zika vaccine induces potent Zika and dengue antibodies

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Ansley Kahn
GHTC
Read More
Congress passes final FY20 spending packages marked by continued support for global health R&D
Flickr/Paolo Rosa
December 19, 2019

Congress passes final FY20 spending packages marked by continued support for global health R&D

This week, months of tense negotiation between leaders in the Democratically-controlled US House of Representatives, the Republican-held Senate, and the White House concluded with the passage of two massive spending packages encompassing all federal government spending for fiscal year (FY) 2020 —nearly three months behind schedule.
Emily Conron GHTC
Read More
Faces of Innovation: Dan Littlefield, researcher at Modality Solutions
GHTC
December 17, 2019

Faces of Innovation: Dan Littlefield, researcher at Modality Solutions

Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Dan Littlefield, who we met at the American Society of Tropical Medicine and Hygiene Annual Conference. Dan co-founded a cold-chain engineering company that worked with the Centers for Disease Control and Prevention and the Biomedical Advanced Research and Development Authority to distribute Ebola vaccines for clinical trials in Sierra Leone.

Julien Rashid GHTC
Read More
Faces of Innovation: Dr. Aileen Marty, researcher at Florida International University
GHTC
November 25, 2019

Faces of Innovation: Dr. Aileen Marty, researcher at Florida International University

Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Dr. Aileen Marty, who we met at the American Society of Tropical Medicine and Hygiene Annual Conference. Dr. Marty works at Florida International University and serves on the President’s Advisory Council for Combating Antibiotic-Resistant Bacteria.

Julien Rashid GHTC
Read More
Faces of Innovation: Dr. Heinz Weidenthaler, researcher at Bavarian Nordic
GHTC
November 22, 2019

Faces of Innovation: Dr. Heinz Weidenthaler, researcher at Bavarian Nordic

Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Dr. Heinz Weidenthaler, who we met at the American Society of Tropical Medicine and Hygiene (ASTMH) Annual Conference, who developed a smallpox and monkeypox vaccine with Bavarian Nordic.

Marissa Chmiola GHTC
Read More
Faces of Innovation: Dr. Mary Kamb, researcher at CDC
November 22, 2019

Faces of Innovation: Dr. Mary Kamb, researcher at CDC

Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Dr. Mary Kamb, who we met at the American Society of Tropical Medicine and Hygiene Annual Conference, who leads the Elimination and Control Epidemiology team at the Centers for Disease Control and Prevention, Division of Parasitic Diseases and Malaria.

Ansley Kahn
GHTC
Read More
Faces of Innovation: Mohammad Ariful Islam, researcher at icddr,b
GHTC
November 22, 2019

Faces of Innovation: Mohammad Ariful Islam, researcher at icddr,b

Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Mohammad Ariful Islam, who we met at the American Society of Tropical Medicine and Hygiene Annual Conference. Ariful researches influenza in Bangladesh with funding from the US Centers for Disease Control and Prevention.

Julien Rashid GHTC
Read More
Faces of Innovation: Dr. Mark Kortepeter, researcher at University of Nebraska
GHTC
November 21, 2019

Faces of Innovation: Dr. Mark Kortepeter, researcher at University of Nebraska

Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Dr. Mark Kortepeter, who we met at the American Society of Tropical Medicine and Hygiene (ASTMH) Annual Conference, who does research on emerging infectious diseases at the University of Nebraska in Lincoln.

Marissa Chmiola GHTC
Read More
Research Roundup: the threat of antibiotic resistant infections, J&J Ebola vaccine roll out in DRC, and Merck Ebola vaccine granted marketing approval by European Commission
PATH/Felix Masi
November 18, 2019

Research Roundup: the threat of antibiotic resistant infections, J&J Ebola vaccine roll out in DRC, and Merck Ebola vaccine granted marketing approval by European Commission

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn
GHTC
Read More
Members of Congress push back at President’s budget cuts to global health research
April 26, 2019

Members of Congress push back at President’s budget cuts to global health research

The Trump administration’s budget request for fiscal year 2020 (FY20) includes cuts that—if enacted—would hamstring the research and development (R&D) of new global health technologies. Since the release of the budget request in early March, however, lawmakers from both parties have expressed their commitment to shielding critical funding strings from the president’s scissors.

Julien Rashid GHTC
Read More
Five issues to watch in US global health R&D policy in 2018
PATH/Aaron Joel Santos
January 8, 2018

Five issues to watch in US global health R&D policy in 2018

2018 is shaping up to be another important year for US policy related to global health and medical research. As Congress returns for a busy work session and the White House continues to roll out policy reforms, here are the top five issues GHTC will be following in 2018.

Courtney Carson
GHTC
Read More
Celebrating ten years of GHTC & a decade of progress in global health innovation
December 17, 2017

Celebrating ten years of GHTC & a decade of progress in global health innovation

As we close out our 10th anniversary year, we wanted to take a moment to reflect on our shared progress and celebrate the headlines and moments that shaped global health R&D over the past decade. Check out some of the highlights...

Marissa Chmiola GHTC
Read More
Global health and medical research saved from spending cuts in FY17 budget agreement
Architect of the Capitol
May 2, 2017

Global health and medical research saved from spending cuts in FY17 budget agreement

What global health R&D advocates need to know about the FY2017 budget agreement.

Courtney Carson
GHTC
Read More
Research Roundup: Breaking down Zika and opportunities, challenges surrounding global immunization
PATH/Aaron Joel Santos
April 30, 2017

Research Roundup: Breaking down Zika and opportunities, challenges surrounding global immunization

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Taylor Capizola
GHTC
Read More
New information for innovation: Antimicrobial Resistance Isolate Bank
US Centers for Disease Control and Prevention
September 14, 2016

New information for innovation: Antimicrobial Resistance Isolate Bank

A new tool from the US Centers for Disease Control and Prevention is helping researchers develop diagnostic tests and antibiotics to combat the growing problem of antibiotic resistance.

Beth Bell US Centers for Diseases Control and Prevention
Read More
From DC to Atlanta: Becoming Better Advocates for CDC Global Health Programs on Capitol Hill
Courtney Carson/GHTC
August 10, 2016

From DC to Atlanta: Becoming Better Advocates for CDC Global Health Programs on Capitol Hill

Global health advocates traveled to the US Centers for Disease Control and Prevention last month. Here's what they learned about the agency's work.

Danielle Heiberg Global Health Council
Read More
President will redirect Ebola funds for Zika, but where is the money from and where will it go?
April 7, 2016

President will redirect Ebola funds for Zika, but where is the money from and where will it go?

The Administration announced that it will transfer nearly $600 million in remaining Ebola funds to fight the growing threat of Zika virus. But many questions remain. Where is the money going? What accounts is it coming from? And what does this mean for the Global Health Security Agenda?

Courtney Carson
GHTC
Read More
  • 1
  • 2
  • Next
advancing innovation to save lives

© 2009–2021, PATH, as secretariat of the Global Health Technologies Coalition.
Header Photo: PATH/Evelyn Hockstein

  • Stay Informed
  • Join Us
  • Contact Us
  • GHTC Member Log In